ECO Animal Health Group Future Growth
Future criteria checks 4/6
ECO Animal Health Group is forecast to grow earnings and revenue by 46.3% and 6.7% per annum respectively. EPS is expected to grow by 77.7% per annum. Return on equity is forecast to be 2.7% in 3 years.
Key information
46.3%
Earnings growth rate
77.7%
EPS growth rate
Pharmaceuticals earnings growth | 14.7% |
Revenue growth rate | 6.7% |
Future return on equity | 2.7% |
Analyst coverage | Low |
Last updated | 25 Apr 2024 |
Recent future growth updates
Recent updates
ECO Animal Health Group plc (LON:EAH) Shares Could Be 46% Below Their Intrinsic Value Estimate
Apr 10Is There An Opportunity With ECO Animal Health Group plc's (LON:EAH) 38% Undervaluation?
Sep 16Are Investors Undervaluing ECO Animal Health Group plc (LON:EAH) By 44%?
Apr 18An Intrinsic Calculation For ECO Animal Health Group plc (LON:EAH) Suggests It's 38% Undervalued
Dec 22Calculating The Fair Value Of ECO Animal Health Group plc (LON:EAH)
Mar 17ECO Animal Health Group's (LON:EAH) Solid Earnings Have Been Accounted For Conservatively
Dec 02ECO Animal Health Group plc (LON:EAH) Shares Could Be 48% Below Their Intrinsic Value Estimate
Nov 16Are Investors Undervaluing ECO Animal Health Group plc (LON:EAH) By 39%?
Apr 30Analysts Are Betting On ECO Animal Health Group plc (LON:EAH) With A Big Upgrade This Week
Mar 09Investors Who Bought ECO Animal Health Group (LON:EAH) Shares A Year Ago Are Now Up 58%
Mar 06Is ECO Animal Health Group (LON:EAH) Using Too Much Debt?
Feb 08An Intrinsic Calculation For ECO Animal Health Group plc (LON:EAH) Suggests It's 49% Undervalued
Dec 18Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 110 | 5 | 6 | 7 | 1 |
3/31/2026 | 99 | 3 | 4 | 6 | 3 |
3/31/2025 | 93 | 3 | 4 | 6 | 4 |
3/31/2024 | 89 | 2 | 3 | 7 | 4 |
9/30/2023 | 88 | -2 | 13 | 19 | N/A |
6/30/2023 | 87 | 0 | 12 | 17 | N/A |
3/31/2023 | 85 | 1 | 10 | 16 | N/A |
12/31/2022 | 82 | 1 | 2 | 7 | N/A |
9/30/2022 | 79 | 1 | -7 | -2 | N/A |
6/30/2022 | 80 | 0 | -5 | -1 | N/A |
3/31/2022 | 82 | -1 | -3 | -1 | N/A |
12/31/2021 | 92 | 2 | 4 | 6 | N/A |
9/30/2021 | 102 | 4 | 11 | 12 | N/A |
6/30/2021 | 104 | 6 | 11 | 12 | N/A |
3/31/2021 | 106 | 7 | 11 | 12 | N/A |
12/31/2020 | 96 | 7 | 8 | 10 | N/A |
9/30/2020 | 86 | 5 | 5 | 7 | N/A |
6/30/2020 | 79 | 5 | 3 | 6 | N/A |
3/31/2020 | 72 | 4 | 2 | 4 | N/A |
12/31/2019 | 69 | 4 | 0 | 3 | N/A |
9/30/2019 | 66 | 5 | -2 | 1 | N/A |
6/30/2019 | 66 | 6 | 0 | 4 | N/A |
3/31/2019 | 67 | 7 | 3 | 6 | N/A |
12/31/2018 | 70 | 10 | 5 | 12 | N/A |
9/30/2018 | 68 | 9 | 8 | 13 | N/A |
6/30/2018 | 68 | 9 | 7 | 14 | N/A |
3/31/2018 | 67 | 9 | 7 | 14 | N/A |
12/31/2017 | 65 | 10 | 6 | 14 | N/A |
9/30/2017 | 64 | 11 | 6 | 14 | N/A |
6/30/2017 | 63 | 11 | N/A | 13 | N/A |
3/31/2017 | 61 | 11 | N/A | 12 | N/A |
12/31/2016 | 57 | 9 | N/A | 9 | N/A |
9/30/2016 | 53 | 8 | N/A | 6 | N/A |
6/30/2016 | 50 | 7 | N/A | 4 | N/A |
3/31/2016 | 47 | 6 | N/A | 2 | N/A |
12/31/2015 | 45 | 5 | N/A | 4 | N/A |
9/30/2015 | 44 | 5 | N/A | 6 | N/A |
6/30/2015 | 41 | 4 | N/A | 7 | N/A |
3/31/2015 | 39 | 4 | N/A | 7 | N/A |
12/31/2014 | 36 | 4 | N/A | 7 | N/A |
9/30/2014 | 34 | 4 | N/A | 7 | N/A |
6/30/2014 | 33 | 3 | N/A | 6 | N/A |
3/31/2014 | 32 | 2 | N/A | 6 | N/A |
9/30/2013 | 33 | 3 | N/A | 6 | N/A |
6/30/2013 | 31 | 3 | N/A | 5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EAH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.6%).
Earnings vs Market: EAH is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: EAH is expected to become profitable in the next 3 years.
Revenue vs Market: EAH's revenue (6.7% per year) is forecast to grow faster than the UK market (3.4% per year).
High Growth Revenue: EAH's revenue (6.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EAH's Return on Equity is forecast to be low in 3 years time (2.7%).